More information: Shuanzeng Wei et al, NFIB::PHACTR2, a novel atypical fusion gene identified in adenoid cystic carcinoma of the palate, Virchows Archiv (2025). DOI: 10.1007/s00428-025-04107-4 ...

Background: The standard of care (SOC) over the past two decades for resected locally advanced SCCHN (LA-SCCHN) with high-risk of relapse is adjuvant cisplatin-radiotherapy (CRT). Despite these ...

BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced its participation in The Festival of Genomics & Biodata Bost ...

Renal cell carcinoma is the most common type of kidney cancer, with an overall 5-year survival rate of 75%. Risk factors can include smoking, having overweight, and having a family history of ...

Doctors classify renal cell carcinoma (RCC) into four stages according to the extent to which the cancer has progressed. They usually classify advanced RCC as stage 4.

having a history of a related noncancerous condition, such as atypical hyperplasia or lobular carcinoma in situ exposure to the drug diethylstilbestrol (DES), used between 1940 and 1971 Trusted Source ...

Proton therapy is a type of external beam radiation therapy that delivers high dose radiation directly to cancer cells. Learn about its benefits and uses for breast cancer treatment.

Background: Becotatug vedotin (MRG003) is a novel EGFR-targeted antibody-drug conjugate. Previous Phase I/II studies have demonstrated optimistic efficacy in R/M NPC pts who had failed platinum ...